The Clinical Relevance of Pollen Versus Fungal Spores in Allergic Diseases

Rosa Codina1, Robert E Esch2, Richard F Lockey3

  • 1Allergen Science & Consulting, Lenoir, NC; Division of Allergy and Immunology, Department of Internal Medicine, Morsani College of Medicine, University of south Florida, Tampa, Fla.

Insights

Pollen and fungal spores cause allergies, but fungal allergy diagnosis is challenging due to difficult-to-produce extracts. Standardized pollen extracts exist, but clinically relevant fungal extracts are needed for accurate diagnosis and treatment of allergic diseases.

Area of Science:

  • Allergy and Immunology
  • Environmental Health
  • Biotechnology

Background:

  • Pollen and fungal spores are common causes of seasonal and perennial allergic diseases.
  • Current scientific literature indicates pollen allergy is considered more clinically significant than fungal allergy.
  • Several factors contribute to this disparity, including environmental variables and challenges in producing reliable fungal extracts.

Purpose of the Study:

  • To highlight the complexities in assessing allergen exposure to both pollen and fungal spores.
  • To emphasize the necessity of understanding allergen properties and cross-reactivity for accurate evaluation.
  • To underscore the difficulties in obtaining clinically relevant fungal extracts compared to standardized pollen extracts.

Main Methods:

  • Review of existing scientific literature on pollen and fungal allergies.
  • Analysis of factors influencing airborne allergen levels, including biodiversity, taxonomy, and meteorology.
  • Comparison of raw materials and manufacturing processes for pollen and fungal extracts.

Main Results:

  • Accurate measurement of both pollen and fungal allergen exposure is challenging.
  • Understanding allergen enzymatic nature, modulating substances, and cross-reactivity is crucial for evaluation.
  • Pollen extracts are relatively consistent and standardized, whereas clinically relevant fungal extracts are difficult to obtain.

Conclusions:

  • The development of reliable and standardized fungal extracts is essential.
  • Improved diagnostic and therapeutic approaches for fungal-induced allergic diseases are needed.
  • Standardized fungal extracts will enable more appropriate diagnosis and treatment of both pollen- and fungal-induced allergic conditions.

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
29.4K
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.1K
Cross-reactivity00:42

Cross-reactivity

Overview
31.9K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
894
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.4K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.4K